Pharmaceuticals (100) | Registration Rights Agreements (100)

Browse by Company

Recent Contracts

Registration Rights Agreement, dated February 18, 2021, by and between Evolus, Inc. and Medytox, Inc (Evolus, Inc., Filed With SEC on May 12, 2021)
Arena Registration Rights Agreement (Canbiola, Inc., Filed With SEC on April 14, 2021)
Registration Rights Agreement, dated as of April 12, 2021, by and among Liquidia Corporation and the Purchasers (Liquidia Corp, Filed With SEC on April 13, 2021)
Registration Rights Agreement, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC (Jaguar Health, Inc., Filed With SEC on April 8, 2021)
Registration Rights Agreement (Terra Tech Corp., Filed With SEC on March 30, 2021)
Form of Registration Rights Agreement (ADIAL PHARMACEUTICALS, INC., Filed With SEC on March 15, 2021)
Registration Rights Agreement, dated February 12, 2021, by and among the Registrant and the Investors named therein (resTORbio, Inc., Filed With SEC on March 12, 2021)
Form of Registration Rights Agreement (Hoth Therapeutics, Inc., Filed With SEC on March 9, 2021)
Registration Rights Agreement to be effective on March 3, 2021 (Satsuma Pharmaceuticals, Inc., Filed With SEC on March 1, 2021)
Third Amended and Restated Registration Rights Agreement of the Registrant dated April 4, 2016, as amended by Amendment No. 1 dated December 13, 2017, of the Registrant (Kala Pharmaceuticals, Inc., Filed With SEC on February 25, 2021)